Precigen beats Q2 estimates with GAAP EPS of $0.05 and revenue of $54.98M

Earnings
โดย Seeking Alpha·Read original
Summary · why it matters

Precigen reported second-quarter 2026 financial results that exceeded analyst expectations. The company posted GAAP earnings per share of $0.05, beating estimates by $0.06. Revenue reached $54.98 million, surpassing forecasts by $27.15 million. The results were highlighted by accelerating momentum for Papzimeos.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
Precigen Inc
PGEN
▲ PositiveCapitalrelevance

Beats Q2 estimates with EPS and revenue above forecasts.

© 2026 MarketDXNews